Sven-Erik Lennart Nilsson

Sven-Erik Lennart Nilsson

Chief Executive Officer at ENKAM Pharmaceuticals A/S

83 year
Health Technology
Commercial Services
Distribution Services

Profile

Sven-Erik Lennart Nilsson is the founder of HemoCue AB, which was founded in 1982.
Currently, he is the Chief Executive Officer at ENKAM Pharmaceuticals A since 2018.
He also holds director positions at Protista International AB, Migrata U.K.
Ltd., Aksen SA, Protista Food AB, and Cambo Holdings Ltd.
In the past, he has worked as a director at Remedium Oy, Tigran Technologies AB, and Sufucell AB.

Sven-Erik Lennart Nilsson active positions

CompaniesPositionStart
Director/Board Member -
Aksen SA Director/Board Member 2011-10-31
Chief Executive Officer 2018-05-30
Director/Board Member 2011-10-31
Protista Food AB Director/Board Member 2011-10-31
Cambo Holdings Ltd. Director/Board Member 2011-10-31
All active positions of Sven-Erik Lennart Nilsson

Former positions of Sven-Erik Lennart Nilsson

CompaniesPositionEnd
Director/Board Member 2006-10-29
Founder -
Sufucell AB Director/Board Member -
░░░░░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of Sven-Erik Lennart Nilsson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sven-Erik Lennart Nilsson's experience

Connections

12

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies10

Commercial Services

Distribution Services

Health Technology

Aksen SA

Health Technology

Commercial Services

Protista Food AB

Sufucell AB

Cambo Holdings Ltd.

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Sven-Erik Lennart Nilsson